Luo, Li <br/><br/>
Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Sep 2018 
 - 841-847 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2018.03.058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bleomycin--toxicity<br/>Calcium-Binding Proteins--deficiency<br/>Cell Line<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Pulmonary Fibrosis--chemically induced<br/>Signal Transduction--drug effects<br/>Smad2 Protein--antagonists & inhibitors<br/>Smad3 Protein--antagonists & inhibitors<br/>Transforming Growth Factor beta1--antagonists & inhibitors